The current proposed extension of the transition period for medical devices can alleviate some of the concerns on certifying existing medical devices and avoid shortage of medical devices. It remains to be seen if the additional time and notified bodies will be sufficient to address pending research and clinical investigations which require also to be addressed by the notified bodies.
VUB
VUB
Academic / research · Belgium
2
positions filed
in the 583 files tracked
2
legislative files
of 583 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track VUB in PolicySpeak: request access →
Work at VUB? so we know who speaks for it.
Their record over time
VUB filed 2 positions between 18 Jan 2023 and 10 Feb 2026, across 2 of the 583 legislative files tracked here.
2023 · 1 filed2026 · 1 filed
What they argued
All these actions and initiatives should think outside of the box. While it is great that women are encouraged to be more involved in research, innovation and startups, but lack of encouragement is not the reason why there is low participation from women. In fact, from education perspective, the participation of women in STEM, research and innovation is strong.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put VUB next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from VUB’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.